Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis.
Journal: The Journal of clinical investigation
Published: October 26, 2021
The state of melanoma: challenges and opportunities.
Journal: Pigment cell & melanoma research
Published: March 04, 2016
Symmetry breaking in spreading RAT2 fibroblasts requires the MAPK/ERK pathway scaffold RACK1 that integrates FAK, p190A-RhoGAP and ERK2 signaling.
Journal: Biochimica et biophysica acta
Published: January 18, 2016
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.
Journal: Oncotarget
Published: August 20, 2015
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.
Journal: PloS one
Published: April 27, 2015
Integrin adjunct therapy for melanoma.
Journal: Pigment cell & melanoma research
Published: September 30, 2014
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.
Journal: Head & neck
Published: June 27, 2014
p70S6 kinase is a critical node that integrates HER-family and PI3 kinase signaling networks.
Journal: Cellular signalling
Published: February 24, 2014
Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma.
Journal: Leukemia
Published: August 28, 2013
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 27, 2013
Last Updated: 09/26/2026